Standort: ---
Exemplare:
---
| |  Online-Ressource |
|---|
| Verfasst von: | Hassel, Jessica C. [VerfasserIn]  |
|---|
| Titel: | Checkpoint blocker induced autoimmunity as an indicator for tumour efficacy in melanoma |
|---|
| Verf.angabe: | Jessica C. Hassel |
|---|
| Jahr: | 2022 |
|---|
| Umfang: | 2 S. |
|---|
| Fussnoten: | Gesehen am 14.09.2023 ; Online veröffentlicht: 25. Oktober 2021 |
|---|
| Titel Quelle: | Enthalten in: British journal of cancer |
|---|
| Ort Quelle: | Edinburgh : Nature Publ. Group, 1999 |
|---|
| Jahr Quelle: | 2022 |
|---|
| Band/Heft Quelle: | 126(2022), 2, Seite 163-164 |
|---|
| ISSN Quelle: | 1532-1827 |
|---|
| Abstract: | Immune checkpoint inhibitors (ICI) have improved survival of patients with metastatic melanoma but can induce autoimmunologic side effects. Ye et al. report a retrospective analysis that further supports the finding that these are biomarkers for patients’ clinical benefit. Thereby, patients with immune-related adverse events show a differential gene expression in chemokine-mediated signalling. |
|---|
| DOI: | doi:10.1038/s41416-021-01390-1 |
|---|
| URL: | kostenfrei: Volltext: https://doi.org/10.1038/s41416-021-01390-1 |
|---|
| | kostenfrei: Volltext: https://www.nature.com/articles/s41416-021-01390-1 |
|---|
| | DOI: https://doi.org/10.1038/s41416-021-01390-1 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Biomedicine |
|---|
| | Cancer Research |
|---|
| | Drug Resistance |
|---|
| | Epidemiology |
|---|
| | general |
|---|
| | Molecular Medicine |
|---|
| | Oncology |
|---|
| K10plus-PPN: | 185952656X |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
| |
|
|---|
| | |
|---|
| Lokale URL UB: |  Zum Volltext |
|---|
Checkpoint blocker induced autoimmunity as an indicator for tumour efficacy in melanoma / Hassel, Jessica C. [VerfasserIn]; 2022 (Online-Ressource)
69121844
